Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00453843 · ClinicalTrials.gov registry record · Phase 2

Shoulder, or Elbow, or Wrist: What Should we Train First After a Stroke?

A Phase 2 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
Phase 2
Development phase
190
Enrollment target

NCT00453843: Completed Phase 2 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT00453843 is a Phase 2 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 190 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (43% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00453843, a Phase 2 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
Phase 2
Development phase
190 participants
Enrollment target

Study Summary

We will test on persons with chronic impairment due to stroke: 1. whether the order in which robot therapy is delivered influences outcomes (shoulder-and-elbow before wrist vs. wrist before shoulder-and-elbow). 2. whether we should train the shoulder, elbow, and wrist at the same time or on different days.

Interventions

  • DEVICE rehabilitation robotics
  • PROCEDURE Movement therapy

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2004-06
Est. Completion 2010-12
Phase Phase 2

What the finished NCT00453843 record still lists

NCT00453843 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (43% higher).

The record links to 0 conditions, and to 2 interventions - of which rehabilitation robotics is the first listed.

NCT00453843 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00453843 about?

NCT00453843 is a clinical study titled "Shoulder, or Elbow, or Wrist: What Should we Train First After a Stroke?". We will test on persons with chronic impairment due to stroke: 1. whether the order in which robot therapy is delivered influences outcomes (shoulder-and-elbow before wrist vs. wrist before shoulder-and-elbow). 2. whether we should train the shoulder, elbow, and wrist at the same time or on differe...

What is the current status of trial NCT00453843?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 190 participants. The study started on 2004-06. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00453843?

The interventions under investigation include: rehabilitation robotics (DEVICE), Movement therapy (PROCEDURE).

Who is sponsoring clinical trial NCT00453843?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00453843's enrollment target sits among peer trials

190 353rd of 2000 higher than 1,646 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03257033 · 190 participants · Phase 3

    Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

  • NCT03642028 · 190 participants · Phase 4

    Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

  • NCT04015609 · 190 participants · NA

    Psychotherapy Intervention for Latinos With Advanced Cancer

  • NCT04284397 · 190 participants · Early Phase 1

    Identification of Critical Thermal Environments for Aged Adults

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00453843, the US trial registry maintained by the National Library of Medicine. NCT00453843 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.